Development of an effective contemporary trivalent avian influenza vaccine against circulating H5N1, H5N8, and H9N2 in Egypt
Open Access
- 1 December 2019
- journal article
- Published by Elsevier BV in Poultry Science
- Vol. 98 (12), 6289-6295
- https://doi.org/10.3382/ps/pez385
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- US Department of Health and Human Services (HHSN272201400006C)
- Egyptian Science and Technology Development Fund (5175)
This publication has 11 references indexed in Scilit:
- Efficacy of commercial vaccines against newly emerging avian influenza H5N8 virus in EgyptScientific Reports, 2018
- Multiple Introductions of Influenza A(H5N8) Virus into Poultry, Egypt, 2017Emerging Infectious Diseases, 2018
- Multiple introductions of reassorted highly pathogenic avian influenza viruses (H5N8) clade 2.3.4.4b causing outbreaks in wild birds and poultry in EgyptInfection, Genetics and Evolution, 2018
- Novel reassortant H9N2 viruses in pigeons and evidence for antigenic diversity of H9N2 viruses isolated from quails in EgyptJournal of General Virology, 2017
- Avian Influenza A(H5N1) Virus in EgyptEmerging Infectious Diseases, 2016
- Active Surveillance for Avian Influenza Virus, Egypt, 2010–2012Emerging Infectious Diseases, 2014
- Do commercial avian influenza H5 vaccines induce cross-reactive antibodies against contemporary H5N1 viruses in Egypt?Poultry Science, 2013
- Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1)Vaccine, 2008
- Epidemiological Findings of Outbreaks of Disease Caused by Highly Pathogenic H5N1 Avian Influenza Virus in Poultry in Egypt During 2006Avian Diseases, 2008
- Enhanced growth of seed viruses for H5N1 influenza vaccinesVirology, 2007